Currently, Murphy group efforts are focused on two main areas:
1) Development of new methods to chemically-modify silk-based materials for applications such as targeted drug delivery or tumor imaging. 2) Design and synthesis of conducting polymers and conducting polymer - biopolymer composites for use as artificial muscles, implantable electrodes and drug delivery vehicles.